αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum

• DOI: 10.1371/journal.pone.0235136
• Publication Date: 2020-12-04T23:06:35Z
• Authors: Sara Morais; Jorge Oliveira; Catarina Lau; Mónica Pereira; Marta Gonçalves; Catarina Monteiro; Ana Rita Gonçalves; Rui Matos; Marco Sampaio; Eugénia Cruz; Inês Freitas; Rosário Santos; Margarida Lima
• Keywords: Male; Protein Conformation; Science; Q; R; Integrin alpha2; Integrin beta3; Mutation, Missense; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Mutation; Medicine; Humans; Female; Research Article; Thrombasthenia

BackgroundRare pathogenic variants in either theITGA2BorITGB3genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thrombocytopenia.ObjectivesTo describe a series of patients with familial macrothrombocytopenia and decreased expression of αIIbβ3 integrin due to defects in theITGA2BorITGB3genes.MethodsWe reviewed the clinical and laboratory records of 10 Portuguese families with GTLS (33 patients and 11 unaffected relatives), including the functional and genetic defects.ResultsPatients had absent to moderate bleeding, macrothrombocytopenia, low αIIbβ3 expression, impaired platelet aggregation/ATP release to physiological agonists and low expression of activation-induced binding sites on αIIbβ3 (PAC-1) and receptor-induced binding sites on its ligand (bound fibrinogen), upon stimulation with TRAP-6 and ADP. Evidence for constitutive αIIbβ3 activation, occurred in 2 out of 9 patients from 8 families studied, but also in 2 out of 12 healthy controls. We identified 7 missense variants: 3 inITGA2B(5 families), and 4 inITGB3(5 families). Three variants (αIIb: p.Arg1026Trp and p.Arg1026Gln and β3: p.Asp749His) were previously reported. The remaining (αIIb: p.Gly1007Val and β3: p.Thr746Pro, p.His748Pro and p.Arg760Cys) are new, expanding the αIIbβ3 defects associated with GTLS. The integration of the clinical and laboratory data allowed the identification of two GTLS subgroups, with distinct disease severity.ConclusionsPreviously reportedITGA2BandITGB3variants related to thrombocytopenia were clustered in a confined region of the membrane-proximal cytoplasmic domains, the inner membrane clasp. For the first time, variants are reported at the outer membrane clasp, at the transmembrane domain of αIIb, and at the membrane distal cytoplasmic domains of β3. This is the largest single-center series of inherited macrothrombocytopenia associated with αIIbβ3 variants published to date.